T&L Co., Ltd. Stock

Equities

A340570

KR7340570001

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 06:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
58,700 KRW -4.40% Intraday chart for T&L Co., Ltd. -0.84% +46.75%
Sales 2024 * 136B 99.71M Sales 2025 * 162B 119M Capitalization 474B 346M
Net income 2024 * 35B 25.58M Net income 2025 * 44B 32.16M EV / Sales 2024 * 2.96 x
Net cash position 2024 * 69.9B 51.1M Net cash position 2025 * 104B 76.1M EV / Sales 2025 * 2.28 x
P/E ratio 2024 *
13.5 x
P/E ratio 2025 *
10.7 x
Employees 142
Yield 2024 *
1.11%
Yield 2025 *
1.24%
Free-Float 53.11%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.40%
1 week-0.84%
Current month+9.51%
1 month+15.55%
3 months+34.02%
6 months+43.52%
Current year+46.75%
More quotes
1 week
58 300.00
Extreme 58300
63 000.00
1 month
50 700.00
Extreme 50700
63 500.00
Current year
37 500.00
Extreme 37500
63 500.00
1 year
37 500.00
Extreme 37500
63 500.00
3 years
27 000.00
Extreme 27000
63 500.00
5 years
18 225.00
Extreme 18225
63 500.00
10 years
18 225.00
Extreme 18225
63 500.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 -
Chief Tech/Sci/R&D Officer 54 -
Director/Board Member 55 -
Members of the board TitleAgeSince
Director/Board Member 60 -
Chief Executive Officer 65 -
Director/Board Member 59 -
More insiders
Date Price Change Volume
24-04-23 58,700 -4.40% 141,652
24-04-22 61,400 -2.07% 115,115
24-04-19 62,700 +3.81% 224,509
24-04-18 60,400 -1.15% 115,544
24-04-17 61,100 +3.21% 155,653

End-of-day quote Korea S.E., April 22, 2024

More quotes
T&L Co Ltd is a Korea-based company engaged in the manufacture and sale of wound treatment materials. The Company's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The company sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
58,700 KRW
Average target price
61,500 KRW
Spread / Average Target
+4.77%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A340570 Stock